J. Cramer, R. Rosenheck, and G. Kirk, Medication Compliance Feedback and Monitoring in a Clinical Trial: Predictors and Outcomes, Value in Health, vol.6, issue.5, pp.566-73, 2003.
DOI : 10.1046/j.1524-4733.2003.65269.x

R. Haynes, D. Sackett, and E. Gibson, Improvement of medication compliance in uncontrolled hypertension, Lancet, vol.1, pp.1265-1273, 1976.

B. Blackwell, From compliance to alliance A quarter century of research, The Netherlands Journal of Medicine, vol.48, issue.4, pp.140-149, 1996.
DOI : 10.1016/S0300-2977(96)80017-9

R. Greenberg, Overview of patient compliance with medication dosing: a literature review, Clin Ther, vol.6, pp.592-601, 1984.

D. Christensen, Drug-taking compliance: a review and synthesis, Health Serv Res, vol.198, pp.171-187, 1978.

J. Cramer, Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence, Am J Managed Care, vol.4, pp.1563-1571, 1998.

R. Haynes and R. Dantes, Patient compliance and the conduct and interpretation of therapeutic trials, Controlled Clinical Trials, vol.8, issue.1, pp.12-21, 1987.
DOI : 10.1016/0197-2456(87)90021-3

J. Cramer and B. Spilker, Patient compliance in medical practice and clinical trials, 1991.

D. Moher, K. Schulz, D. Altman, and . Group, The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials, JAMA, vol.285, issue.15, pp.1987-91, 2001.
DOI : 10.1001/jama.285.15.1987

M. Nichol, F. Venturini, and J. Sung, A Critical Evaluation of the Methodology of the Literature on Medication Compliance, Annals of Pharmacotherapy, vol.50, issue.5, pp.531-571, 1999.
DOI : 10.1097/00005650-198601000-00007

A. Claxton, J. Cramer, and C. Pierce, A systematic review of the associations between dose regimens and medication compliance, Clinical Therapeutics, vol.23, issue.8, pp.1296-310, 2001.
DOI : 10.1016/S0149-2918(01)80109-0

N. Olivieri, D. Matsui, and C. Hermann, Compliance assessed by the Medication Event Monitoring System., Archives of Disease in Childhood, vol.66, issue.12, pp.1399-402, 1991.
DOI : 10.1136/adc.66.12.1399

J. Lang, J. Buring, and B. Rosner, Estimating the effect of the run-in on the power of the physicians' health study, Statistics in Medicine, vol.80, issue.10, pp.1585-93, 1991.
DOI : 10.1002/sim.4780101010

S. Van-rooyen, F. Godlee, and S. Evans, Effect of Blinding and Unmasking on the Quality of Peer Review, JAMA, vol.280, issue.3, pp.234-241, 1998.
DOI : 10.1001/jama.280.3.234

A. Justice, J. Berlin, and S. Fletcher, Do Readers and Peer Reviewers Agree on Manuscript Quality?, JAMA: The Journal of the American Medical Association, vol.272, issue.2, pp.117-126, 1994.
DOI : 10.1001/jama.1994.03520020043011

A. Jadad, R. Moore, and D. Carroll, Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Controlled Clinical Trials, vol.17, issue.1, pp.1-12, 1996.
DOI : 10.1016/0197-2456(95)00134-4

A. Verhagen, H. De-vet, and R. De-bie, The Delphi List, Journal of Clinical Epidemiology, vol.51, issue.12, pp.1235-1276, 1998.
DOI : 10.1016/S0895-4356(98)00131-0

A. Verhagen, H. De-vet, and F. Vermeer, The influence of methodologic quality on the conclusion of a landmark meta-analysis on thrombolytic therapy

C. Hill, . Lm, and D. Felson, Discrepancy between published report and actual conduct of randomized clinical trials, Journal of Clinical Epidemiology, vol.55, issue.8, pp.783-789, 2002.
DOI : 10.1016/S0895-4356(02)00440-7

H. Maenpaa, V. Manninen, and O. Heinonen, Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial, European Heart Journal, vol.8, issue.suppl I, pp.39-43, 1987.
DOI : 10.1093/eurheartj/8.suppl_I.39

J. Melkinow and C. Kiefe, Patient compliance and medical research: issues in methodology, J Gen Intern Med, vol.9, pp.96-105, 1994.

P. Rudd, R. Byyny, and V. Zachary, The natural history of medication compliance in a drug trial: Limitations of pill counts, Clinical Pharmacology and Therapeutics, vol.46, issue.2, pp.169-76, 1989.
DOI : 10.1038/clpt.1989.122

H. Caron, Compliance: the case for objective measurement, J Hypertens, vol.3, issue.1, pp.11-18, 1985.

A. Mushlin and F. Appel, Diagnosing Potential Noncompliance, Archives of Internal Medicine, vol.137, issue.3, p.318, 1977.
DOI : 10.1001/archinte.1977.03630150030010

J. Lindsey and N. Mcgrath, Interpreting Treatment Differences When Patients Drop Out of a Clinical Trial, AIDS Patient Care and STDs, vol.12, issue.4, pp.275-85, 1998.
DOI : 10.1089/apc.1998.12.275

J. Hogan and N. Laird, Intention-to-Treat Analyses for Incomplete Repeated Measures Data, Biometrics, vol.52, issue.3, pp.1002-1019, 1996.
DOI : 10.2307/2533061

K. Lee, M. Schotland, and P. Bacchetti, Association of Journal Quality Indicators With Methodological Quality of Clinical Research Articles, JAMA, vol.287, issue.21, pp.2805-2813, 2002.
DOI : 10.1001/jama.287.21.2805